metformin has been researched along with Leishmaniasis, Cutaneous in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin (MET) is a hypoglycemic drug used for the treatment of diabetes, despite interference in host immunity against microorganisms." | 1.56 | Metformin promotes susceptibility to experimental Leishmania braziliensis infection. ( Arruda, S; Bonyek-Silva, I; Carvalho Filho, EM; Ferreira, LM; Lima, FR; Malta, TA; Santos, RL; Tavares, NM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lima, FR | 1 |
| Ferreira, LM | 1 |
| Malta, TA | 1 |
| Bonyek-Silva, I | 1 |
| Santos, RL | 1 |
| Tavares, NM | 1 |
| Carvalho Filho, EM | 1 |
| Arruda, S | 1 |
1 other study available for metformin and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Metformin promotes susceptibility to experimental Leishmania braziliensis infection.
Topics: Animals; Brazil; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Metformin; Mice; Mic | 2020 |